Nivolumab
In unresectable/metastatic urothelial carcinoma, upfront nivolumab/chemotherapy prolongs survival
SG Tylor
Source –Bristol-Myers Squibb Nivolumab plus chemotherapy showed statistically significant and clinically meaningful improvements in progression-free survival (PFS) and overall survival ...
Nivolumab and Ipilimumab Together Prolong Survival in Metastatic RCC
SG Tylor
Kidney cancer, or renal cell carcinoma (RCC), is one of the most common types of cancer in adults, affecting about ...
98% ORR in Early-Stage Classical Hodgkin Lymphoma with Brentuximab Vedotin + Nivolumab/Chemo
SG Tylor
Source – Seagen Frontline treatment with the combination of brentuximab vedotin (Adcetris), nivolumab (Opdivo), doxorubicin, and dacarbazine led to an ...
